Department of Public Health Publications Kansanterveystieteen laitos Julkaisut 2005

Department of Public Health Publications 2005 Kansanterveystieteen laitos Julkaisut 2005 Kansanterveystieteen laitos Department of Public Health PL 41 (Mannerheimintie 172) 00014 Helsingin Yliopisto Sirkka Koskinen (ed.) Kansanterveystieteen laitos Department of Public Health 1

Department of Public Health Publications 2005 Kansanterveystieteen laitos - Julkaisut 2005 Scientific or scholarly monographs and all dissertations, even if they are published in a department series (A1) Hildén H-M. Making decisions in the face of death. Physicians and nurses views of end-of-life decision-making and patient participation. Yliopisto: Helsinki, University of Helsinki, 2005. 94 p. ISBN 952-10-1368-0. ISSN 0355-7979. Dissertation. Kieseppä T. A twin study on genetic and environmental factors in Bipolar I disorder. Publications of the National Public Health Institute A19/2005. Helsinki: Edita Prima Oy, University of Helsinki, 2005, 86 p. ISBN 951-740- 562-6. ISBN 951-740-563-4 (pdf). ISSN 0359-3584. ISSN 1458-6290 (pdf). Dissertation. Montonen J. Plant foods in the prevention of type 2 diabetes mellitus with emphasis on dietary fiber and antioxidant vitamins. Publications of the National Public Health Institute A13/2005. Helsinki: Edita Prima Oy, University of Helsinki, 2005. 150 p. ISBN 951-740-538-3. ISBN 951-740-539-1 (pdf). ISSN 0359-3584; 1458-6290 (pdf). Dissertation. Pärna K. Socioeconomic differences in smoking in Estonia: National and international comparisons. Publications of Public Health Science M187:2005. Helsinki: Yliopistopaino, University of Helsinki, 2005. 83 p. ISBN 952-10- 1369-9. ISBN 952-10-2853-X (pdf). ISSN 0355-7979. Dissertation. Tuomilehto J. Lifestyle intervention in type 2 diabetes and other conditions associated with insulin resistance. Worthing: Cambridge Medical Publications, 2005:28. Wang J. Assessment of the metabolic syndrome in predicting incident type 2 diabetes in a Chinese population. Publications of the National Public Health Institute A15/2005. Helsinki: Edita Prima Oy, University of Helsinki, 2005. 69 p. ISBN 951.740-553-7. ISSN 0359-3584. ISBN 951-740-554-5 (pdf). ISSN 1458-6290 (pdf). Dissertation. Scientific or scholarly monographs edited or translated by the person, whose authorship is to recorded (A3) Fredriksson H, Klockars M. Time the impact on body and soul. Acta Gyllenbergiana V. Helsinki: Oy Nord Print Ab, 2005:150. ISBN 951-98786-3-2

7. Linko L, Lampe K, Ihalainen J, Mäkelä M, Sintonen S ja työryhmä. Verensokerin omaseuranta diabeteksen hoidossa. FinOHTAn raportti 24/2005. Saarijärvi: Gummeruksen Kirjapaino, 2005:82. ISBN 951-33-1769-2. ISSN 1239-6273. Myhrman R, Aromaa A, Blanco Sequieros M, Bjuström L-M, Ericksson R, Hansson A-I, Hartman J, Heikkilä M, Holi T, Huuskonen MS, Hämäläinen H, Leppo K, Lindgvist-Virtanen C, Lindross K, Simpura J, Vasama J, Heino T. Social Welfare and Health care. Data and Information reform 2005 Working Group Report. Sosiaali- ja terveysministeriö, Helsinki 2004. Työryhmämuistioita 2004:12. 71 p. Textbooks (A4) Tuomilehto J, Hu G, Qiao Q. Management of cardiovascular risk factors in patients with metabolic syndrome and type 2 diabetes. 2005. Scientific or scholarly articles in scientific or scholarly journals that use the referee evaluation system (B1) Aittomäki A, Lahelma E, Roos E, Leino-Arjas P, Martikainen P. Gender differences in the association of age with physical workload and functioning. Occup Environ Med 2005;62:2:95-100. Impact factor 1.916 Autti-Rämö I, Mäkelä M, Sintonen H, Koskinen H, Laajalahti L, Halila R, Kääriäinen H, Lapatto R, Näntö-Salonen K, Pulkki K, Renlund M, Salo M, Tyni T. Expanding screening for rare metabolic disease in the newborn: An analysis of costs, effect and ethical consequences for decision-making in Finland. Acta Paediatr 2005;94:8:1126-36. Impact factor 1.143 Backman T, Rauramo I, Jaakkola K, Inki P, Vaahtera K, Launonen A, Koskenvuo M. Use of Levonorgestrel-releasing intrauterine system and breast cancer. Obstet & Gynecol 2005;106:4:813-7. Impact factor 3.512 Baker SG, Lichtenstein P, Kaprio J, Holm N. Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins. Biometrics 2005;61:55-63. Impact factor 1.211 Barengo NC, Hu G, Kastarinen M, Lakka T, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical activity as a predictor for antihypertensive drug treatment in 25-64-year-old populations in eastern and south-western Finland. J Hypertens 2005;23:2:293-9. Impact factor 4.871 3

Beisswenger P, Heine RJ, Leiter LA, Moses A, Tuomilehto J. Prandial glycose regulation in the glucose triad: Emerging evidence and insights. Endocrine 2004;25:3:195-202. Borodulin K, Laatikainen T, Lahti-Koski M, Lakka TA, Laukkanen R, Sarna S, Jousilahti P. Associations between estimated aerobic fitness and cardiovascular risk factors in adults with different levels of abdominal obesity. European Journal of Cardiovascular Prevention & Rehabilitation 2005;12:2:126-31. Impact factor 3.000 Bosnyak Z, Nishimura R, Hagan Huges M, Tajima N, Becker D, Tuomilehto J, Orchard TJ. Excess mortality in Black compared with White patients with Type 1 diabetes: an examination of underlying causes. Diabet Med 2005;22:1636-41. Impact factor 2.725 Brommels M. Systeemi, prosessi vai potilas? Duodecim 2005;121:15:1605-6. Cannon TD, Hennah W van Erp TG, Thompson PM, Lönnqvist J, Huttunen M, Gasperoni T, Tuulio-Henriksson A, Pirkola T, Toga AW, Kaprio J, Mazziotta J, Peltonen L. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry 2005;62:1205-13. Impact factor 11.207 Ceriello A, Hanefeld M, Leiter L, Monnier L, Owens D, Tajima N, Tuomilehto J, The International Prandial Glucose Regulation Study Group. To: Strey CH, Young J, Collier M, Florkowski CM, Shand Bl, Scott RS (2004). The postprandial state does not impair endothelial function in women with type 2 diabetes irrespective of glycaemic control. Diabetologia 47:1838-46. Diabetologia 2005;48:1423-24. Impact factor 5.583 Dahlberg A, Alaranta H, Sintonen H. Health-related quality of life in persons with traumatic spinal cord lesion in Helsinki. J Rehabil Med 2005;37:5:312-6. Impact factor 1.600 Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers GB, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O Brien E, Östergren, for the ASCOT investigators (Tuomilehto J). Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a multicentre randomized controlled trial. Lancet 2005;366:895-906. Impact factor 23.878 Dalstra JAA, Kunst AE, Borrell C, Breeze E, Cambois E, Costa G, Geurts JJM, Lahelma E, Van Oyen H, Rasmussen NK, Regidor E, Spadea T, Mackenbach JP. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol 2005;34:2:316-26. Impact factor 3.735 4

Dalstra J, Kunst A, Mackenbach J, the EU Working Group on Socioeconomic Inequalities in Health (Lahelma E). A comparative appraisal of the relationship of education, income and housing tenure with less than good health among the elderly in Europe. Soc Sci Med 2006;8:2046-60. Decode Study Group (Qiao Q, Tuomilehto J.) Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? Diabet Med 2005;22:1476-81. Impact factor 2.621 Decode Study Group (Qiao Q, Tuomilehto J.) Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans. Br J Diabetes Vasc Dis 2005;5:161-8. Dick DM, Viken RJ, Kaprio J, Pulkkinen L, Rose RJ. Understanding the covariation among childhood externalizing symptoms: genetic and environmental influences on conduct disorder; attention deficit hyperactivity disorder, and oppositional defiant disorder symptoms. J Abnorm Child Psychol 2005;33:2:219-29. Impact factor 2.317 Dong Y, Gao W, Nan H, Yu H, Li F, Duan W, Wang Y, Sun S, Qian R, Tuomilehto J, Qiao Q. Prevalence of type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabet Med 2005;22:1427-33. Impact factor 2.621 Eriksson CJP, Kaprio J, Pulkkinen L, Rose RJ. Testosterone and alcohol use among adolescent male twins: testing between-family associations in withinfamily comparisons. Behav Genet 2005;35:3:359-68. Impact factor 2.215 Erkkilä L, Jauhiainen M, Laitinen K, Haasio K, Tiirola T, Saikku P, Leinonen M. Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice. Antimicrob Agents Chemother 2005;49:9:3959-62. Impact factor 4.216 Giskes K, Kunst AE, Benach J, Borrell C, Costa G, Dahl E, Dalstra JAA, Federico B, Helmert U, Judge K, Lahelma E, Moussa K, Östergren PO, Platt S, Prättälä R, Rasmussen NK, Mackenbach JP. Trends in smoking behaviour between 1985 and 2000 in nine European countries by education. J Epidemiol Community Health 2005;59:395-401. Impact factor 2.836 Haanpää L, Kivipelto L, Pohjola J, Sintonen H, Hernesniemi J. Pään alueen neuralgisten kipujen hoito. Duodecim 2005;121:687-95. Haarasilta L, Marttunen M, Kaprio J, Aro H. Major depressive episode and physical health in adolescents and young adults: results from a populationbased interview survey. Eur J Public Health 2005;15:5:489-93. Impact factor 1.051 Hannila-Handelberg T, Kontula K, Tikkanen I, Tikkanen T, Fyhrquist F, Helin K, Fodstad H, Piippo K, Miettinen HE, Virtamo J, Krusius T, Sarna S, Gautschi I, Schild L, Hiltunen TP. Common variants of the beta and gamma 5

subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension. BMC Medical Genetics 2005;6:4:1. Impact factor 0.001 Hannukainen JC, Kujala UM, Toikka J, Heinonen OJ, Kapanen J, Vahlberg T, Kaprio J, Kalliokoski KK. Cardiac structure and function in monozygotic twin pairs discordant for physical fitness. J Appl Physiol 2005;99:2:535-41. Impact factor 2.824 Harjutsalo V, Podar T, Tuomilehto J. Cumulative incidence of type 1 Diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes 2005;54:2:563-9. Impact factor 8.848 Heinonen-Guzejev M, Vuorinen HS, Mussalo-Rauhamaa H, Heikkilä K, Koskenvuo M, Kaprio J. Genetic component of noise sensitivity. Twin Research and Human Genetics 2005;8:3:245-9. Impact factor 0.001 Heinonen-Guzejev M, Vuorinen HS, Heikkilä K, Koskenvuo M, Kaprio J. Somatic and psychological characteristics of noise-sensitive adults in Finland. Arch Environ Health 2004;59:8:410-7. Impact factor 0.913 Heinävaara S, Hakulinen T. Predicting the lung cancer burden: Accounting for selection of the patients with respect to general population mortality. Stat Med 2006;9:1135-44. Impact factor 1.389 Hemilä H, Louhiala P. Vitamin C for preventing and treating pneumonia. The Cochrane Database of Systematic Reviews 2005;4. Impact factor 0.001 http://gateway.uk.ovid.com/gw1/ovidweb.cgi Hildén HM, Honkasalo ML, Louhiala P. Finnish doctors and the realisation of patient autonomy in the context of end of life decision making. J Med Ethics 2006;6:316-20. Impact factor 1.353 Hirvonen J, van Erp TG, Huttunen J, Aalto S, Någren K, Huttunen M, Lönnqvist J, Kaprio J, Hietala J, Cannon TD. Increased caudate dopamine D 2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry 2005;62:4:371-8. Impact factor 11.207 Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI. Normal serum pepsinogen l levels in adults: A population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies. Scand J Clin Lab Invest 2005;65:4:291-300. Impact factor 1.039 Horneman G, Folkesson P, Sintonen H, von Wendt L, Emanuelson I. Healthrelated quality of life of adolescents and young adults 10 years after serious traumatic brain injury. Int J Rehabil Res 2005:28:3:245-9. Impact factor 0.648 Hosia-Randell H, Pitkälä K. Use of psychotropic drugs in elderly nursing home 6

residents with and without dementia in Helsinki, Finland. Drugs Aging 2005;22:9:793-800. Impact factor 2.048 Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 2005;28:799-805. Impact factor 7.071 Hu G, Jousilahti P, Peltonen M, Lindström J, Tuomilehto J. Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland. Diabetologia 2005;48:8:1477-83. Impact factor 5.583 Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J. Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 2005;36:1994-9. Impact factor 5.748 Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Antikainen R, Tuomilehto J. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 2005;36:2538-43. Impact factor 5.748 Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P. The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes 2005;29:8:894-902. Impact factor 3.459 Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 2005 May ;48:5:856-61. Impact factor 5.583 Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The genderspecific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 2005;45:1413-8. Impact factor 9.133 Häkkinen A, Kautiainen H, Sintonen H, Ylinen J. Health related quality of life after lumbar disc surgery: A prospective study of 145 patients. Disabil Rehabil 2005 Feb 4;27:3:94-100. Impact factor 1.144 Hämäläinen H, Rönnemaa T, Virtanen A, Lindström J, Eriksson JG, Valle TT, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Rastas M, Aunola S, Uusitupa M, Tuomilehto J on behalf of the Finnish Diabetes Prevention Study. Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study. Diabetologia 2005;48:2248-53. Impact factor 5.583 Hämäläinen J, Poikolainen K, Isometsä E, Kaprio J, Heikkinen M, Lindeman S, Aro H. Major depressive episode related to long unemployment and frequent alcohol intoxication. Nord J Psychiatry 2005;59:6:486-91. Impact factor 0.964 7

Jaakkola JJK, Hwang B-F, Jaakkola N. Home dampness and molds, parental atopy, and asthma in childhood: A six-year population-based cohort study. Environ Health Perspect 2005;113:3:357-61. Impact factor 3.929 Jaakkola E, Herzberg I, Laiho K, Barnardo MCNM, Pointon JJ, Kauppi M, Kaarela K, Tuomilehto-Wolf E, Tuomilehto J, Wordsworth BP, Brown MA. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 2006;6:775-80. Impact factor 3.916 Javela K, Eronen J, Sarna S, Kekomäki R. Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation. Transfusion 2005;45:9:1504-11. Impact factor 3.708 Jousilahti P, Salomaa V, Kuulasmaa K, Niemelä M, Vartiainen E. Total and cause specific mortality among participants and non-participants of population based health surveys: a comprehensive follow up of 54 372 Finnish men and women. J Epidemiol Community Health 2005;59:310-5. Impact factor 3.003 Jussila M, Sintonen H, Koivula I, Lumio J. Hengitystieinfektioiden hoito terveyskeskuksessa potilaan, lääkärin ja yhteiskunnan näkökulma. Suomen Lääkäril 2005;60:2577-82. Järvenpää T, Rinne JO, Koskenvuo M, Räihä I, Kaprio J. Binge drinking in midlife and dementia risk. Epidemiology 2005;16:6:766-71. Impact factor 3.840 Jörgensen L, Hammar N, Kaprio J, Koskenvuo M, Svensson Å. Migration and smoking: An epidemiological study of Finnish twins in Sweden. Scand J Public Health 2005;33:4:285-91. Impact factor 1.030 Kaarisalo MM, Räihä I, Sivenius J, Immonen-Räihä P, Lehtonen A, Sarti C, Mähönen M, Torppa J, Tuomilehto J, Salomaa V. Diabetes worsens the outcome of acute ischemic stroke. Diabetes Res Clin Pract 2005;69:3:293-8. Impact factor 1.730 Kalme T, Seppälä M, Qiao Q, Koistinen R, Nissinen A, Harrela M, Loukovaara M, Leinonen P, Tuomilehto J. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab 2005;90:3:1550-6. Impact factor 5.778 Katoh S, Lehtovirta M, Kaprio J, Harjutsalo V, Koskenvuo M, Eriksson J, Tajima N, Tuomilehto J. Genetic and environmental effects on fasting and postchallenge plasma glucose and serum insulin values in Finnish twins. J Clin Endocrinol Metab 2005;90:5:2642-7. Impact factor 5.778 Kattainen E, Sintonen H, Kettunen R, Meriläinen P. Health-related quality of life of coronary artery bypass grafting and percutaneous transluminal coronary 8

artery angioplasty patients: 1-year follow-up. Int J Technol Assess Health Care 2005;21:2:172-9. Impact factor 1.039 Kaunisto MA, Tikka PJ, Kallela M, Leal SM, Papp JC, Korhonen A, Hämäläinen E, Harno H, Havanka H, Nissilä M, Säkö E, Ilmavirta M, Kaprio J, Färkkilä M, Ophoff RA, Palotie A, Wessman M. Chromosome 19p13 loci in Finnish migraine with aura families. Am J Med Genet, Part B, Neuropsychiatric Genetics 2005;132B:1:85-9. Impact factor 2.000 Kauppinen T, Koskela A, Diemling M, Keski-Rahkonen A, Sihvola E, Ahonen A. Comparison of manual and automated quantification methods of 1231- ADAM. Nuklearmedizin 2005;44:205-12. Impact factor 1.95 Keski-Rahkonen A, Bulik CM, Neale BM, Rose RJ, Rissanen A, Kaprio J. Body dissatisfaction and drive for thinness in young adult twins. Int J Eat Disord 2005;37:3:188-99. Impact factor 1.867 Keski-Rahkonen A, Neale BM, Bulik CM, Pietiläinen KH, Rose RJ, Kaprio J, Rissanen A. Intentional weight loss in young adults: Sex-specific genetic and environmental effects. Obes Res 2005;13:4:745-53. Impact factor 3.701 Keski-Rahkonen A, Tozzi F. The process of recovery in eating disorder sufferers own words: an Internet-based study. Int J Eat Disord 2005;37 Suppl S80-6; discussion S87-9. Impact factor 1.867 Kestilä L, Koskinen S, Martelin T, Rahkonen O, Pensola T, Aro H, Aromaa A. Determinants of health in early adulthood: what is the role of parental education, childhood adversities and own education? Eur J Public Health 2006;3:306-15. Impact factor 1.051 Kieseppä T, Tuulio-Henriksson A, Haukka J, van Erp T, Glahn D, Cannon TD, Partonen T, Kaprio J, Lönnqvist J. Memory and verbal learning functions in twins with bipolar-i disorder, and the role of information-processing speed. Psychol Med 2005;35:205-15. Impact factor 2.943 Kinnunen ML, Kaprio J, Pulkkinen L. Allostatic load of mean and women in early middle age. J Indiv Differences 2005;26:20-8. Impact factor 0.001 Kinnunen ML, Kokkonen M, Kaprio J, Pulkkinen L. The associations of emotion regulation and dysregulation with the metabolic syndrome factor. J Psychosom Res 2005;58:6:513-21. Impact factor 2.811 Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, Helkala E-L, Tuomilehto J, Soininen H, Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556-60. Impact factor 4.835 Koivumaa-Honkanen H, Kaprio J, Honkanen RJ, Viinamäki H, Koskenvuo M. The stability of life satisfaction in a 15-year follow-up of adult Finns healthy at baseline. BMC Psychiatry 2005;5:1:4. Impact factor 0.001 9

Korkeila K, Korkeila J, Vahtera J, Kivimäki M, Kivelä S-L, Sillanmäki L, Koskenvuo M. Childhood adversities, adult risk factors and depressiveness. A population study. Soc Psychiatry Epidemiol 2005;40:700-6. Impact factor 1.535 Koskela R-S, Mutanen P, Sorsa JA. Klockars M. Respiratory disease and cardiovascular morbidity. Occup Environ Med 2005;62:650-5. Impact factor 1.916 Kosunen TU, Seppälä K, Sarna S, Aromaa A, Knekt P, Virtamo J, Salomaa- Räsänen A, Rautelin H. Association of Helicobacter pylori IgA antibodies with the risk of peptic ulcer disease and gastric cancer. World J Gastroenterol 2005;21:11:43:6871-4. Impact factor 0.001 Kujala UM, Sarna S, Kaprio J. Cumulative incidence of Achilles tendon rupture and tendinopathy in male former elite athletes. Clin J Sport Med 2005; May:15:3:133-5. Impact factor 1.430 Kunst AE, Bos V, Lahelma E, Bartley M, Lissau I, Regidor E, Mielck A, Cardano M, Dalstra JAA, Geurts JJM, Helmert U, Lennartsson C, Ramm J, Spadea T, Stronegger WJ, Mackenbach JP. Trends in socioeconomic inequalities in self-assessed health in 10 European countries. Int J Epidemiol 2005;34:295-305. Impact factor 3.735 Laajalahti L, Sintonen H. Nivelreuman hoidon kustannukset ja vaikutus elämänlaatuun. Suomen Lääkäril 2005;60:51-52:5293-6. Laaksonen DE, Lindström J, Lakka TA, Eriksson JG, Niskanen L, Wikström K, Aunola S, Keinänen-Kiukaanniemi S, Laakso M, Valle TT, Ilanne-Parikka P, Louheranta A, Hämäläinen H, Rastas M, Salminen V, Cepaitis Z, Hakumäki M, Kaikkonen H, Härkönen P, Sundvall J, Tuomilehto J, Uusitupa M, for the Finnish Diabetes Prevention Study Group. Physical activity in the prevention of type 2 diabetes: The Finnish diabetes prevention study. Diabetes 2005;54:1:158-65. Impact factor 8.848 Laaksonen M, Rahkonen O, Karvonen S, Lahelma E. Socioeconomic status and smoking. Analysing inequalities with multiple indicators. Eur J Public Health 2005;15:3:262-9. Impact factor 1.051 Laaksonen M, Rahkonen O, Martikainen P, Lahelma E. Socioeconomic position and self-rated health: the contribution of childhood socioeconomic circumstances, adult socioeconomic status, and material resources. Am J Public Health 2005 Aug;95:8:1403-9. Impact factor 3.241 Laaksonen M, Roos E, Rahkonen O, Martikainen P, Lahelma E. Influence of material and behavioural factors on occupational class differences in health. J Epidemiol Community Health 2005;59:2:163-9. Impact factor 2.836 Laaksonen M, Rahkonen O, Martikainen P, Lahelma E. Socioeconomic 10

position and self-rated health. The contribution of childhood socioeconomic circumstances, adult socioeconomic status and material resources. Am J Public Health 2005;95:1403-9. Impact factor 3.566 Laaksonen M, Sarlio-Lähteenkorva S, Leino-Arjas P, Martikainen P, Lahelma E. Body weight and health status: Importance of socioeconomic position and working conditions. Obes Res 2005;13:12:2169-77. Lahelma E, Martikainen P, Rahkonen O, Roos E, Saastamoinen P. Occupational class inequalities across key domains of health: Results from the Helsinki Health Study. Eur J Public Health 2005;15:5:504-10. Impact factor 1.051 Lallukka T, Laaksonen M, Martikainen P, Sarlio-Lähteenkorva S, Lahelma E. Psychosocial working conditions and weight gain among employees. Int J Obes 2005;29:8:909-15. Impact factor 3.459 Lammi N, Karvonen M, Tuomilehto J. Do microbes have a causal role in type 1 diabetes? Medical Science Monitor 2005;11:3:RA63-9. Impact factor 0.001 Laukkanen O, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne- Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M. The Finnish Diabetes Study. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes. Diabetes 2005;54:7:2256-60. Impact factor 8.848 Lehtonen-Smeds EMP, Mäyränpää M, Lindsberg PJ, Soinne L, Saimanen E, Järvinen AAJ, Salonen O, Carpén O, Lassila R, Sarna S, Kaste M, Kovanen PT. Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and symptomatic carotid artery disease. Cerebrovasc Dis 2005;19:5:291-301. Impact factor 2.150 Lehtovirta M, Kaprio J, Groop L, Trombetta M, Bonadonna RC. Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. Diabetologia 2005;48:8:1604-13. Impact factor 5.583 Leinonen R, Kaprio J, Jylhä M, Tolvanen A, Koskenvuo M, Heikkinen E, Rantanen T. Genetic influences underlying self-rated health in older female twins. J Am Geriatr Soc 2005;53:6:1002-7. Impact factor 3.361 Lewington DJ, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg- Hansen A, Haverkate F, de Maat MP, Thompson SG, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D Aglostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Pinango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriguez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Coll E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson 11

H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Iso H, Salomaa V, Harald K, Rasi V, Vahtera W, Jousilahti P, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Meade TW, Rudnicka A, Knottenbelt C, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;12:294:14:1799-809. Impact factor 24.831 Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B, on behalf of the ASCOT investigators (Tuomilehto J). Costeffectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm (ASCOT-LLA). European Journal of Cardiovascular Prevention and Rehabilitation 2005;12:29-36. Impact factor 3.000 Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E. Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens 2005;19:5:373-9. Impact factor 1.930 Lindström J, Peltonen M, Tuomilehto J, for the Finnish Diabetes Prevention Study Group. Lifestyle strategies for weight control: experience from the Finnish Diabetes Prevention Study. Proc Nutr Soc 2005;64:1:81-8. Impact factor 2.202 Louhiala P, Hemilä H. Näyttöön perustuva lääketiede hyvä renki mutta huono isäntä. Duodecim 2005;121:1317-25. Louhiala P, Hildén HM. Suomalaisten lääkärien näkemykset aktiivisesta eutanasiasta vuonna 2003. Suomen lääkäril 2005;60:36:3519-21. Mackenbach JP, Martikainen P, Looman CW, Dalstra JAA, Kunst AE, Lahelma E, members of the SEdHA working group. The shape of the relationship between income and self-assessed health: an international study. Int J Epidemiol 2005;34:2:286-93. Impact factor 3.735 Malmberg LP, Turpeinen H, Rytilä P, Sarna S, Haahtela T. Determinants of increased exhaled nitric oxide in patients with suspected asthma. Allergy 2005;464-8. Impact factor 3.496 Mentula P, Kylänpää ML, Kemppainen E, Jansson SE, Sarna S, Puolakkainen P, Haapiainen R, Repo H. Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg 2005;92:1:68-12

75. Impact factor 3.580 Mikkelsson L, Kaprio J, Kautinen H, Nupponen H, Tikkanen MJ, Kujala UM. Endurance running ability at adolescence as a predictor of blood pressure levels and hypertension in men: a 25-year follow-up study. Int J Sports Med 2005;26:448-52. Impact factor 1.357 Mikkelsson L, Kaprio J, Kautiainen H, Kujala UM, Nupponen H. Associations between self-estimated and measured physical fitness among 40-year-old men and women. Scand J Med Sci Sports 2005;15:5:329-35. Impact factor 1.717 Mohlke KL, Jackson AU, Scott LJ, Peck EC, Suh YD, Chines PS, Watanabe RM, Buchanan TA, Conneely KN, Erdos MR, Narisu N, Enloe S, Valle TT, Tuomilehto J, Bergman RN, Boehnke M, Collins FS. Mitochondrial polymorphisms and susceptibility to type2 diabetes-related traits in Finns. Hum Genet 2005;118:245-54. Impact factor 4.328 Mohlke KL, Skol AD, Scott LJ, Valle TT, Bergman RN, Tuomilehto J, Boehnke M, Collins FS, for the FUSION Study Group. Evaluation of SLC2A10 (GLUT10) as a candidate gene for type 2 diabetes and related traits in Finns. Mol Genet Metab 2005;85:4:323-7. Impact factor 2.502 Moltchanova EV, Pitkäniemi J, Haapala L. Potts model for haplotype associations. BMC Genetics 2005;6:supp.1.:S64. Impact factor 0.924 Mäkinen J, Järvisalo MJ, Pöllänen P, Perheentupa A, Irjala K, Koskenvuo M, Mäkinen J, Huhtaniemi I, Raitakari OT. Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 2005;45:10:1603-8. Impact factor 9.133 Mäkinen T, Laaksonen M, Lahelma E, Rahkonen O. Associations of childhood circumstances with physical and mental functioning in adulthood. Soc Sci Med 2006;8:1831-9. Niemistö L, Rissanen P, Sarna S, Lahtinen-Suopanki T, Lindgren KA, Hurri H. Cost-effectiveness of combined manipulation, stabilizing exercises, and physician consultation compared to physician consultation alone for chronic low back pain. A prospective randomized trial with 2-year follow-up. Spine 2005;30:10:1109-15. Impact factor 2.299 Ojanlatva A, Rautava P, Helenius H, Korkeila K, Sundell J, Kivimäki M, Vahtera J, Mäkinen J, Koskenvuo M. Associations of social support and sex life the HeSSup Study. Patient Education and Counseling 2005;58:71-81. Impact factor 1.429 Pajala S, Era P, Koskenvuo M, Kaprio J, Alén M, Tolvanen A, Tiainen K, Rantanen T. Contribution of genetic and environmental factors to individual differences in maximal walking speed with and without second task in older women. J Gerontol: Med Sci 2005;60A:10:1299-1303. Impact factor 4.122 13

Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä- Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Torppa J, Vuorenmaa T, Lehtonen A, Miettinen H, Mustonen J, Palomäki P, Arstila M, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V. Sydäninfarktidiagnoosin luotettavuus hoitoilmoitus- ja kuolemansyyrekisterissä vuosina 1988-2002. Suomen Lääkäril 2005;60:3883-7. Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä- Koskenkari P, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V. Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardical infarction: the FINAMI Study. Diabetologia 2005;48:2519-24. Impact factor 5.583 Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä- Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Juolevi A, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V. Five-year risk of developing clinical diabetes after first myocardial infarction; the FINAMI study. Diabet Med 2005;22:1334-7. Impact factor 2.621 Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Karja- Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V. The validity of the Finnish hospital discharge register and causes of death register data on coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation 2005; April 12:2:132-7. Impact factor 3.000 Patja K, Jousilahti P, Hu G, Valle T, Qiao Q, Tuomilehto J. Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-aged Finnish men and women. J Intern Med 2005;258:4:356-62. Impact factor 3.590 Peltonen M, Jousilahti P, Patja K, Sandström P, Korpelainen V, Puska P. Lopeta ja voita 2004. Suomen Lääkäril 2005;60:15:1693-6. Penninkilampi-Kerola V, Kaprio J, Moilanen I, Rose RJ. Co-twin dependence modifies heritability of abstinence and alcohol use: a population-based study of Finnish twins. Twin Res Hum Genet 2005 Jun;8:3:232-44. Penninkilampi-Kerola V, Moilanen I, Kaprio J. Co-twin dependence, social interactions, and academic achievement: A population-based study. Journal of Social and Personal Relationships 2005;22:4:519-41. Impact factor 0.823 Pietiläinen KH, Rissanen A, Kaprio J, Mäkimattila S, Häkkinen AM, Westerbacka J, Sutinen J, Vehkavaara S, Yki-Järvinen H. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance 14

in young adult monozygotic twins. Am J Physiol Endocrinol Metab Endo 2005;288:4:E768-74. Impact factor 4.431 Pirkola T, Tuulio-Henriksson A, Glahn D, Kieseppä T, Haukka J, Kaprio J, Lönnqvist J, Cannon TD. Spatial working memory function in twins with schizophrenia and bipolar disorder. Biol Psychiatry 2005;Aug 19:930-6. Impact factor 6.159 Portegijs E, Sipilä S, Alen M, Kaprio J, Koskenvuo M, Tiainen K, Rantanen T. Leg extension power asymmetry and mobility limitation in healthy older women. Arch Phys Med Rehabil 2005;86:9:1838-42. Impact factor 1.656 Poulter NR, Wedel H, Dahlöf B, Sever P, Beevers DG, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O Brien E, Östergren J, Pocock S, for the ASCOT investigators (Tuomilehto J). Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005;366:907-13. Impact factor 21.713 Rahkonen O, Laaksonen M, Karvonen S. The contribution of lone parenthood and economic difficulties to smoking. Soc Sci Med 2005;61:211-6. Impact factor 2.088 Rahkonen O, Lahelma E. Terveyttä määrittävät sosiaaliset tekijät WHO:n kohteena. Suomen Lääkäril 2005;60:20:2257-8. Rajecki M, Pajunen P, Jousilahti P, Rasi V, Vahtera E, Salomaa V. Hemostatic factors as predictors of stroke and cardiovascular diseases: the FINRISK 92 Hemostasis Study. Blood Coagul Fibrinolysis 2005;16:2:119-124. Ramachandran A, Chamukuttan S, Immaneni S, Shanmugam RM, Vishnu N, Viswanathan V, Tuomilehto J. High incidence of glucose intolerance in Asian- Indian subjects with acute coronary syndrome. Diabetes Care 2005;28:2492-6. Impact factor 7.071 Raulio S, Roos E, Rahkonen O, Prättälä R. Twenty-year trends of workplace lunches in Finland. Food Serviced Technology 2005;5:57-66. Impact factor 0.001 Riusala A, Sarna S, Immonen I. Visual acuity and structural findings in old age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2005;243:9:947-50. Impact factor 1.513 Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H. The burden of mortality attributable to diabetes. Diabetes Care 2005;28:2130-5. Impact factor 7.071 Roos E, Burström B, Saastamoinen P, Lahelma E. A comparative study of the patterning of women s health by family status and employment status in 15

Finland and Sweden. Soc Sci Med 2005;60:11:2443-51. Impact factor 2.088 Roos E, Lahelma E, Rahkonen O. Work-family conflicts and drinking behaviours among employed women and men. Drug Alcohol Depend 2006;83:1:49-56. Impact factor 2.906 Roos E, Lahelma E, Saastamoinen P, Elstad JI. The association of employment status and family status with health among women and men in four Nordic countries. Scand J Public Health 2005;33:4:250-60. Impact factor 0.881 Rouhos A, Ekroos H, Karjalainen J, Sarna S, Sovijärvi AR. Exhaled nitric oxide and exercise-induced bronchoconstriction in young male conscripts: association only in atopics. Allergy 2005;60:12:1493-8. Impact factor 3.496 Rovio S, Kåreholt I, Helkala E-L, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer s disease. Lancet Neurol 2005;4:705-11. Impact factor 8.340 Runstadler JA, Säilä H, Savolainen A, Leirisalo-Repo M, Aho K, Tuomilehto- Wolf E, Tuomilehto J, Seldin MF. Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor-negative juvenile idiopathic arthritis in Finnish patients: Haplotype analysis in Finnish families. Arthritis Rheum 2005;52:1:247-56. Impact factor 7.414 Räsänen P, Sintonen H, Ryynänen OP, Blom M, Semberg-Konttinen V, Roine RP. Measuring cost-effectiveness of secondary health care: Feasibility and potential utilization of results. Int J Technol Assess Health Care 2005; Winter; 21:1:22-31. Impact factor 1.039 Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diabetes Vasc Dis Res 2005;2:67-72. Saastamoinen P, Leino-Arjas P, Laaksonen M, Lahelma E. Socio-economic differences in the prevalence of acute, chronic and disabling chronic pain among ageing employees. Pain 2005;114:364-71. Impact factor 4.061 Salo H, Sintonen H, Nuorti JP, Linna M, Nohynek H, Verho J, Kilpi T. Economic evaluation of pneumococcal conjugate vaccination in Finland. Scand J Infect Dis 2005;37:11-12:821-32. Impact factor 1.141 Salomaa V, Koukkunen H, Ketonen M, Immonen-Räihä P, Kärjä-Koskenkari P, Mustonen J, Lehto S, Torppa J, Lehtonen A, Tuomilehto J, Kesäniemi YA, Pyörälä K, for the FINAMI Study Group. A new definition for myocardial infarction: what difference does it make? Eur Heart J 2005;26:1719-25. Impact factor 6.247 16

Salopuro T, Pulkkinen L, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M for the Finnish Diabetes Prevention Study Group. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study. Int J Obes 2005;29:10:1245-51. Impact factor 3.459 Sarlio-Lähteenkorva S, Lissau I, Lahelma E. The social patterning or relative body weight and obesity in Denmark and Finland. Eur J Public Health 2005;16:1:36-40. Impact factor 1.051 Seldin MF, Shigeta R, Laiho K, Li H, Saila H, Savolainen A, Leirisalo-Repo M, Aho K, Tuomilehto-Wolf E, Kaarela K, Kauppi M, Alexander HC, Begovich AB, Tuomilehto J. Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes and Immunity 2005;6:8:720-2. Impact factor 3.718. Sever PS, Poulter NR, Dahlöf B, Wedel H, Collins R, Beevers G, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O Brien E, Östergren J for the ASCOT Investigators (Tuomilehto J). Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes. Diabetes Care 2005;28:1151-7. Impact factor 7.071 Silventoinen K, Kaprio J. Geenit, ympäristö ja älykkyys. Duodecim 2005;121:2:125-6. Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J. Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. Int J Epidemiol 2005;34:2:327-34. Impact factor 3.735 Silventoinen K, Pankow J, Lindström J, Jousilahti P, Hu G, Tuomilehto J. The validity of the Finnish diabetes risk score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. European Journal of Cardiovascular Prevention and Rehabilitation 2005;12:5:451-8. Impact factor 3.000 Skrifvars MB, Hilden HM, Finne P, Rosenberg PH, Castrén M. Prevalence of do not attempt resuscitation orders and living wills among patients suffering cardiac arrest in four secondary hospitals. Resusitation 2003;58:65-71. Impact factor 1.376 Sulander T, Helakorpi S, Rahkonen O, Nissinen A, Uutela A. Eläkeikäisten elintapojen muutokset 1985-2003. Suomen Lääkäril 2005;60:30-2:2983-8. Sumanen M, Koskenvuo M, Sillanmäki L, Mattila K. Childhood adversities experienced by working aged coronary heart disease patients. J Psychosom Res 2005;59:331-5. Impact factor 2.811 17

Suominen S, Gould R, Ahvenainen J, Vahtera J, Uutela A, Koskenvuo M. Sense of coherence and disability pensions. A nationwide, register based prospective population study of 2196 adult Finns. J Epidemiol Community Health 2005;59:455-9. Impact factor 2.836 Suviolahti W, Reue K, Cantor RM, Phan J, Gentile M, Naukkarinen J, Soro- Paavonen A, Oksanen L, Kaprio J, Rissanen A, Salomaa V, Kontula K, Taskinen MR, Pajukanta P, Peltonen L. Cross-species analyses implicate lipin 1 involvement in human glucose metabolism. Hum Mol Genet 2005: Dec 15. Impact factor 7.80 Sørensen TIA, Rissanen A, Korkeila M, Kaprio J. Intention to lose weight, weight changes, and 18-y mortality in overweight individuals without comorbidities. PLoS Medicine 2005;2:6:e171. Söderberg S, Zimmet P, Tuomilehto J, de Courten M, Dowse GK, Chitson P, Gareeboo H, Alberti KGMM, Shaw JE. Increasing prevalence of type 2 diabetes mellitus in all ethnic groups in Mauritius. Diabet Med 2005;22:1:61-8. Impact factor 2.621 Tervonen H, Bäck L, Juvas A, Räsänen P, Mäkitie AA, Sintonen H, Roine RP, Vilkman E, Aaltonen LM. Automatic speaking valve in speech rehabilitation for laryngectomized patients. Eur Arch Otorhinolaryngol 2005;262:10:816-20. Impact factor 0.673 Tiainen K, Sipilä S, Alén M, Heikkinen E, Kaprio J, Koskenvuo M, Tolvanen A, Pajala S, Rantanen T. Shared genetic and environmental effects on strength and power in older female twins. Med Sci Sports Exerc 2005;37:1:72-8. Impact factor 2.552 Tolonen H, Ferrario M, Kuulasmaa K for the WHO MONICA Project (Tuomilehto J). Standardization of total cholesterol measurement in population surveys pre-analytic sources of variation and their effect on the prevalence of hypercholesterolaemia. European Journal of Cardiovascular Prevention and Rehabilitation 2005;12:257-67. Impact factor 3.000 Tuomilehto J. Cardiovascular risk: Prevention and treatment of the metabolic syndrome. Diabetes Res Clin Pract 2005;68:suppl 2:S28-S35. Impact factor 1.730 Tuomilehto J. Primary prevention of type 2 diabetes: Lifestyle intervention works and saves money, but what should be done with smokers? Ann Int Med 2005;142:5:381-3. Impact factor 13.114 Tuomilehto J, Leiter LA. Defining the role of statins in diabetes. Br J Diabetes Vasc Dis 2005;5:55-62. Impact factor 0.001 Tuomilehto J, Leiter LA, Kallend D. A review of the efficacy of rosuvastatin in patients with type 2 diabetes. Int J Clin Pract Suppl 2004;143:30-40. 18

Tuomilehto J, Lindström J, Qiao Q. Strategies for the prevention of type 2 diabetes and cardiovascular disease. Eur Heart J Suppl 2005;7:Suppl D:D18- D22. Impact factor 1.317 Uusitalo U, Sobal J, Moothoosamy L, Chitson P, Shaw J, Zimmet P, Tuomilehto J. Dietary Westernisation: conceptualization and measurement in Mauritius. Public Health Nutrition 2005;8:6:608-19. Wang JJ, Hu G, Lappalainen J, Miettinen ME, Qing Q, Tuomilehto J. Changes in features of the metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a Chinese population. Diabetes Care 2005;28:2:448-50. Impact factor 7.071 Vehmas T, Jahkola A, Huuskonen MS. Säpsähdyttävästä säteilystä. Duodecim 2005;121:3:328-9. Vehmas T, Kivisaari L, Huuskonen MS, Jaakkola MS. Scoring CT/HRCT findings among asbetos-exposed workers: effects of patient s age, body mass index and common laboratory test results. Eur Radiol 2005;5:2:213-9. Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, Kaprio J. Sleep duration and breast cancer: A prospective cohort study. Cancer Res 2005;65:20:9595-600. Impact factor 7.690 Viinanen A, Munhbayarlah S, Zevgee T, Narantsetseg L, Naidansuren TS, Koskenvuo M, Helenius H, Terho EO. Prevalence of asthma, allergic rhinoconjunctivitis and allergic sensitization in Mongolia. Allergy 2005;60:1370-7. Impact factor 3.496 Winter T, Roos E, Rahkonen O, Martikainen P, Lahelma E. Work-family conflicts and self-rated health among middle-aged municipal employees in Finland. Int J Behav Med 2006;13:4:276-85. Visuri T, Ulaska J, Eskelin M, Pulkkinen P. Narrowing of lumbar spinal canal predicts chronic low back pain more accurately than intervertebral disc degeneration: A magnetic resonance imaging study in young Finnish male conscripts. Mil Med 2005;170:11:926-30. Impact factor 0.001 Von Wendt G, Summanen P, Hallmäs K, Algvere P, Heikkilä K, Seregard S. Detection of diabetic retinopathy: a comparison between red-free digital images and colour transparencies. Graefe s Arch Clin Exp Ophthalmol 2005;243:427-32. Impact factor 1.513 Vorma H, Naukkarinen HH, Sarna SJ, Kuoppasalmi KI. Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependence. Subst Use Misuse 2005;40:4:499-510. Impact factor 0.684 Väistö T, Pajunen P, Jousilahti P, Laatikainen T, Harald K, Vartiainen E, Salomaa V. Valtimotautitapahtumien riskiryhmään kuuluvien ja kuulumattomien kolesterolitasot. Suomen Lääkäril 2005;60:4:389-94. 19

Väkevä L, Sarna S, Vaalasti A, Pukkala E, Kariniemi AL, Ranki A. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides. Acta Derm Venereol 2005;85:4:8-23. Impact factor 1.585 Ylihärsilä H, Lindström J, Eriksson JG, Jousilahti P, Valle TT, Sundvall J, Tuomilehto J. Prevalence of diabetes and impaired glucose regulation in 45- to 64-year-old individuals in three areas of Finland. Diabet Med 2005;22:1:88-91. Impact factor 2.621 Ylikangas S, Sintonen H, Heikkinen J. Decade-long use of continuous combined hormone replacement therapy is associated with better healthrelated quality of life in postmenopausal women, as measured by the generic 15D instrument. Journal of the British Menopause Society 2005;11:4:145-51. Impact factor 0.001 Articles in scientific or scholarly compilation publications or in printed conference publications (B2) Hirvonen J, Blom M, Tuominen U, Hietaniemi K, Lehto MUK, Paavolainen P, Seitsalo S, Sintonen H, Rissanen P, Näsänen J. Paraneeko elämänlaatu, väheneekö lääkkeiden käyttö? Lonkka-artroosipotilaiden elämänlaatu ja lääkkeiden käyttö jonotusaikana ja kolme kuukautta leikkauksen jälkeen. Kirjassa: Klavus J, toim. Terveystaloustiede 2005. Aiheita 3/2005. Helsinki: Stakesin monistamo, 2005:55-60. ISBN 951-33-1612-2. ISSN 1236-9845. Hu G, Qiao Q, Tuomilehto J. Metabolic syndrome, diabetes, and coronary heart disease. In: Marmot M, Elliott P, eds. Great Britain: Coronary Heart Disease Epidemiology, Oxford University Press, 2005;311-24. Hu G, Lakka TA, Barengo NC, Tuomilehto J. Physical activity, physical fitness and the risk of type 2 diabetes. In: Metabolic Syndrome and Related Disorders 2005:35-44. Hujanen T, Sintonen H, Häkkinen U, Noro A, Finne-Soveri H. Pitkäaikaishoidossa hoidettavien vanhusten terveyteen liittyvän elämänlaadun ja hoidon vaikuttavuuden mittaaminen mittarin kehittäminen. Kirjassa: Klavus J, toim. Terveystaloustiede 2005. Aiheita 3/2005. Helsinki: Stakesin monistamo, 2005:71-4. ISBN 951-33-1612-2. ISSN 1236-9845. Huuskonen MS. Asbestos-related diseases. In: Kunnamo I. EBM Guidelines. Editor-in-chief. Helsinki: John Wiley & Sons, Ltd and the Finnish Medical Society Duodecim Medical Publications Ltd, 2005:226-8. Huuskonen MS. Silicosis. In: Kunnamo I. EBM Guidelines. Editor-in-chief. Helsinki: John Wiley & Sons, Ltd and the Finnish Medical Society, Duodecim 20

Medical Publications Ltd, 2005:228-9. Hänninen S, Sarlio-Lähteenkorva S. Naisen ideaalivartalo laihdutustuotemainonnassa ja vaikeasti lihavien laihduttajanaisten puheessa. Naistutkimus 2005;3:30-40. Kaprio J, Marttila R. Demographic trends in Nordic countries. In: Blickstein I, Keith LG, eds. Multiple pregnancy: epidemiology, gestation, and perinatal outcome. Second Edition. 2005:22-5. ISBN 1842142399 Karisto A, Lahelma E. Sosiaalinen ympäristö ja kulttuuriympäristö. Kirjassa: Aromaa A, Huttunen J, Koskinen S, Teperi J, toim. Suomalaisten terveys. Saarijärvi: Saarijärven Offset Oy, 2005:50-3. ISBN 951-656-073-3. Karisto A, Martikainen P, Mäki N, Rahkonen O. Suuren muuton pyörteissä: Liikkuvuus ja liikkumattomuus. Kirjassa: Karisto A, toim. Suuret ikäluokat. Tampere: Vastapaino, 2005:92-114. Lahelma E. Health and social stratification. In: Cockerham W, ed. Blackwell Companion to Medical Sociology. Second edition. Oxford: Blackwell Publishing, 2005;64-93. Lahelma E, Winter T, Martikainen P, Rahkonen O. Työn ja perheen väliset ristiriidat ja niiden taustatekijät naisilla ja miehillä. Työ ja ihminen 2005;19:1:34-48. Louhiala P. Elämän alku. Kirjassa: Aalto K, Tiihonen AL, Virtaniemi MP, Ylikarjula S. Elämän rajallisuus. Sielunhoidon aikakauskirja nro 15. Helsinki: Kirkon sairaalasielunhoito/kirkon perheasiat/kirkon koulutuskeskus 2004. 2004:40-5. ISBN 951-789-162-8. Martelin T, Koskinen S, Lahelma E. Väestöryhmien väliset terveyserot. Kirjassa: Aromaa A, Huttunen J, Koskinen S, Teperi J, toim. Suomalaisten terveys. Saarijärvi: Saarijärven Offset Oy, 2005;266-76. ISBN 951-656-073-3. Rahkonen O, Lahelma E. Terveys hyvinvointivaltiossa Peter Townsendin tulkinta terveyden eriarvoisuudesta. Kirjassa: Saari J, toim. Hyvinvointivaltio. Suomen mallia analysoimassa. Sosiaalipoliittisen yhdistyksen tutkimuksia nro 60. Helsinki: Yliopistopaino, 2005;280-99. ISBN 951-570-604-1. Tuomilehto J. A paradigm shift is needed in the primary prevention of type 2 diabetes. In: Ganz M (ed.). Prevention of type 2 diabetes. Wiltshire: John Wiley & Sons, 2005;153-68. Tuomilehto J, Lindström J. The major diabetes prevention trials. In: Lakhdar A, Gill G, eds. Diabetes in the Arab World. Dubai: FSG Communications Ltd, Ingraphics, 2005;135-52. Tuomilehto J, Lindström J. Lihavuus ja diabetes. In: Lihavuus painavaa 21